ITELZODI Trademark

Trademark Overview

On Thursday, October 8, 2020, a trademark application was filed for ITELZODI with the United States Patent and Trademark Office. The USPTO has given the ITELZODI trademark a serial number of 90242037. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 10, 2023. This trademark is owned by Biogen MA Inc.. The ITELZODI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological and neurodegenerative diseases
itelzodi

General Information

Serial Number90242037
Word MarkITELZODI
Filing DateThursday, October 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological and neurodegenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiogen MA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBiogen MA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, July 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022SOU EXTENSION 3 GRANTED
Thursday, December 1, 2022SOU EXTENSION 3 FILED
Thursday, December 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 16, 2022SOU EXTENSION 2 GRANTED
Monday, May 16, 2022SOU EXTENSION 2 FILED
Monday, May 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 29, 2021SOU EXTENSION 1 GRANTED
Monday, November 29, 2021SOU EXTENSION 1 FILED
Monday, November 29, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 8, 2021ASSIGNED TO EXAMINER
Friday, January 29, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, January 29, 2021ASSIGNED TO LIE
Monday, November 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 20, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, October 12, 2020NEW APPLICATION ENTERED

Related Keywords

itelzodi neurodegenerative diseases neurological treatment preparations pharmaceutical